AQEMIA

About:

Drug discovery - Pharma 3.0

Website: http://www.aqemia.com/

Top Investors: Bpifrance, Eurazeo, Elaia, Wendel Growth

Description:

Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases. What sets us apart is our unique quantum and statistical mechanics algorithms fuelling a generative AI to design novel drug candidates. The disruptive speed and accuracy of our technology platform allows us to scale drug discovery projects as technology projects.

Total Funding Amount:

60.1M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2019-06-13

Founders:

Emmanuelle Rolland-Martiano, Maximilien Levesque

Number of Employees:

51-100

Last Funding Date:

2024-01-30

IPO Status:

Private

© 2024 MyAiNote.com